Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Short Interest Update

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) saw a large increase in short interest in July. As of July 15th, there was short interest totaling 52,162 shares, an increase of 326.1% from the June 30th total of 12,241 shares. Based on an average daily volume of 76,346 shares, the short-interest ratio is presently 0.7 days. Approximately 1.4% of the shares of the stock are short sold.

Invesco Pharmaceuticals ETF Stock Performance

PJP traded up $0.90 during trading on Monday, reaching $121.27. 13,021 shares of the company traded hands, compared to its average volume of 36,220. The company has a market cap of $441.42 million, a P/E ratio of 15.59 and a beta of 0.45. Invesco Pharmaceuticals ETF has a 12-month low of $80.63 and a 12-month high of $122.69. The firm has a fifty day simple moving average of $114.20 and a 200 day simple moving average of $108.59.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Fifth Third Bancorp purchased a new stake in shares of Invesco Pharmaceuticals ETF in the first quarter worth about $36,000. Global Assets Advisory LLC bought a new stake in Invesco Pharmaceuticals ETF in the 1st quarter worth approximately $42,000. IFP Advisors Inc increased its stake in Invesco Pharmaceuticals ETF by 31.3% in the 4th quarter. IFP Advisors Inc now owns 440 shares of the company’s stock worth $46,000 after acquiring an additional 105 shares during the last quarter. International Assets Investment Management LLC purchased a new stake in shares of Invesco Pharmaceuticals ETF during the 4th quarter worth approximately $64,000. Finally, Rockefeller Capital Management L.P. boosted its position in shares of Invesco Pharmaceuticals ETF by 20.5% during the 4th quarter. Rockefeller Capital Management L.P. now owns 1,230 shares of the company’s stock valued at $129,000 after acquiring an additional 209 shares during the last quarter.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.